Literature DB >> 1620345

Spectroscopic imaging of stroke in humans: histopathology correlates of spectral changes.

O A Petroff1, G D Graham, A M Blamire, M al-Rayess, D L Rothman, P B Fayad, L M Brass, R G Shulman, J W Prichard.   

Abstract

Previous studies of human stroke by 1H nuclear magnetic resonance spectroscopy have shown elevation of lactate lasting 3 to 6 months. Complete metabolic turnover of the elevated lactate pool has been demonstrated 5 weeks after a stroke. Its cellular localization is among the first questions requiring clarification. Information pertinent to this question came to us from a patient with a 2-week-old stroke by 1H nuclear magnetic resonance spectroscopic imaging 1 week before his death led to neuropathologic examination of the brain. 1H spectra from voxels including the infarcts showed increased lactate and decreased N-acetylaspartate. Histopathology showed sheets of foamy macrophages in the infarct, but few neurons. Macrophage density ranged from 196 cells/mm2 near the surface of the infarct to 788 near its medial margin. Glial density was 500 to 800 cells/mm2. Lactate concentration in voxels including portions of the infarct was estimated at 7 to 14 mM. Voxels showing low N-acetylaspartate and high lactate on spectroscopic imaging were associated with histopathologic sections containing foamy macrophages. Brain macrophages--which begin to appear 3 days after infarction and gradually disappear over several months--could be a major source of elevated lactate signals that persist for months after stroke.

Entities:  

Mesh:

Year:  1992        PMID: 1620345     DOI: 10.1212/wnl.42.7.1349

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  22 in total

Review 1.  MR spectroscopy and spectroscopic imaging of the brain.

Authors:  He Zhu; Peter B Barker
Journal:  Methods Mol Biol       Date:  2011

2.  The effects of repeated endotoxin exposure on rat brain metabolites as measured by ex vivo 1HMRS.

Authors:  Sulie L Chang; Christine C Cloak; Lorenc Malellari; Linda Chang
Journal:  J Neuroimmunol       Date:  2005-09       Impact factor: 3.478

Review 3.  13C MRS studies of neuroenergetics and neurotransmitter cycling in humans.

Authors:  Douglas L Rothman; Henk M De Feyter; Robin A de Graaf; Graeme F Mason; Kevin L Behar
Journal:  NMR Biomed       Date:  2011-08-31       Impact factor: 4.044

4.  Quantitative neuropathology by high resolution magic angle spinning proton magnetic resonance spectroscopy.

Authors:  L L Cheng; M J Ma; L Becerra; T Ptak; I Tracey; A Lackner; R G González
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

Review 5.  Nuclear magnetic resonance spectroscopy. Principles and applications in neuroophthalmology.

Authors:  A Ettl; C Fischer-Klein; A Chemelli; A Daxer; S Felber
Journal:  Int Ophthalmol       Date:  1994       Impact factor: 2.031

Review 6.  Magnetic resonance imaging biomarkers in patients with progressive ataxia: current status and future direction.

Authors:  Stuart Currie; Marios Hadjivassiliou; Ian J Craven; Iain D Wilkinson; Paul D Griffiths; Nigel Hoggard
Journal:  Cerebellum       Date:  2013-04       Impact factor: 3.847

7.  Implications of immune system in stroke for novel therapeutic approaches.

Authors:  Aaron A Hall; Keith R Pennypacker
Journal:  Transl Stroke Res       Date:  2010-01-13       Impact factor: 6.829

8.  Proton magnetic resonance spectroscopy in patients with ischemic stroke.

Authors:  F Federico; C Conte; I L Simone; P Giannini; M Liguori; E Picciola; C Tortorella; E Ferrari
Journal:  Ital J Neurol Sci       Date:  1994-11

9.  Early and sustained alterations in cerebral metabolism after traumatic brain injury in immature rats.

Authors:  Paula A Casey; Mary C McKenna; Gary Fiskum; Manda Saraswati; Courtney L Robertson
Journal:  J Neurotrauma       Date:  2008-06       Impact factor: 5.269

Review 10.  What might be the impact on neurology of the analysis of brain metabolism by in vivo magnetic resonance spectroscopy?

Authors:  J Vion-Dury; D J Meyerhoff; P J Cozzone; M W Weiner
Journal:  J Neurol       Date:  1994-05       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.